Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment entities : Takeda pharmaceutical company limited save search
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Just crawled : 00:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
| Email alert
Add to watchlist
ALPMF | News | $9.75 43.47% 200
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
granted approval cancer treatment for
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MIRM | $24.4 0.95% 0.94% 420K
|
Health Technology
|
| O: -0.68%
H: 2.52%
C: 1.71%
report million reach treatment market
FDA Approves Takeda’s EOHILIA (budesonide oral suspension), the First and Only Oral Treatment in the U.S. for Eosinophilic Esophagitis (EoE)
Published: 2024-02-12 (Crawled : 14:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.07%
H: 0.46%
C: 0.42%
fda first treatment
Takeda Announces China NMPA Approval of LIVTENCITY® (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Refractory to Prior Therapies
Published: 2023-12-21 (Crawled : 00:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 2.05%
H: 0.29%
C: 0.0%
livtencity approval cytomegalovirus treatment china
Takeda Enters Into Two-Year Contract with Canadian Blood Services for GLASSIA Treatment for Rare form of Emphysema
Published: 2023-12-20 (Crawled : 14:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.36%
H: 0.14%
C: -1.01%
rare services glassia contract treatment blood
FRUZAQLA™ (fruquintinib) Now Available from Onco360 for the Treatment of Adult Patients with Metastatic Colorectal Cancer (mCRC)
Published: 2023-11-21 (Crawled : 18:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.07%
H: 0.57%
C: 0.0%
cancer treatment
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.56 -1.72% -1.75% 340K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.97 6.2% 2.21% 400K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO | $3.73 -1.06% -1.07% 720K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $23.295 1.86% 1.82% 1.9M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
Global Gastroparesis Treatment Market is Expected to Grow Revenue up to USD 11.09 Billion By 2030 with a Growing CAGR of 3.3% | Infinium Global Research
Published: 2023-10-27 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.6%
H: 0.74%
C: 0.07%
PCSA | $1.53 -2.27% 25K
|
Producer Manufacturing
|
| O: -1.15%
H: 5.05%
C: 2.7%
expected treatment research global growing market
Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published: 2023-10-25 (Crawled : 22:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -4.69%
H: 0.69%
C: -3.18%
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: -1.47%
H: 0.22%
C: -0.83%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
bleeding expected reach disorders treatment global market
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
Published: 2023-10-18 (Crawled : 22:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -1.61%
H: 0.14%
C: -0.27%
cd30 adcetris treatment
Takeda Announces FDA Acceptance of NDA Resubmission of TAK-721 (budesonide oral suspension) for the Short-Term Treatment of Eosinophilic Esophagitis (EoE)
Published: 2023-09-20 (Crawled : 14:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.12%
H: 0.43%
C: -0.18%
tak-721 fda resubmission treatment
Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
Published: 2023-09-11 (Crawled : 12:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 1.31%
H: 0.91%
C: 0.52%
tak-279 active positive treatment topline results study
Innovations Redefine Treatment: Antispasmodic Drugs Industry to Reach $17.68 Billion by 2027
Published: 2023-07-26 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.64%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.26%
H: 0.49%
C: 0.39%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.64%
C: 0.34%
reach
HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study
Published: 2023-07-20 (Crawled : 00:00) - globenewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.65%
H: 0.49%
C: 0.07%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.35%
H: 2.21%
C: 1.9%
HCM | $18.2 7.44% 6.92% 120K
|
Health Technology
|
| O: -0.33%
H: 2.55%
C: 1.4%
treatment designation china therapy study
Global Constipation Treatment Markets to 2030: A $27.5 Billion Industry Opportunity with Laxatives Accounting for $12.3 Billion
Published: 2023-06-19 (Crawled : 17:00) - prnewswire.com
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
treatment global
Global Addiction Treatment Market Report 2023: Sector to Reach $11.7 Billion by 2031 at a 6.1% CAGR
Published: 2023-05-26 (Crawled : 00:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
SYK | $334.91 2.21% -4.72% 1.4M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
report reach treatment global market
Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
Published: 2023-05-25 (Crawled : 23:00) - globenewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.62%
H: 0.62%
C: -0.12%
HCM | $18.2 7.44% 6.92% 120K
|
Health Technology
|
| O: 7.45%
H: 3.66%
C: 2.06%
drug review treatment application
Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published: 2023-05-10 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -1.83%
H: 0.12%
C: -3.06%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.4%
H: 0.34%
C: 0.19%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.11%
H: 0.22%
C: -0.52%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.57%
H: 0.37%
C: -0.01%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
disease report treatment research global market
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
Published: 2023-04-27 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -1.13%
H: 0.3%
C: -0.48%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.79%
H: 0.89%
C: 0.72%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.12%
H: 0.58%
C: 0.55%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.25%
H: 0.97%
C: 0.31%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 1.96%
H: 1.59%
C: -0.54%
drug report treatment global growing market
Global Depression Treatment Market to 2030: Rising Prevalence of Psychiatric Diseases and Development of Innovative Medications for Treatment-resistant Depression Drives Growth
Published: 2023-04-04 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.12%
H: 1.55%
C: 1.03%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.38%
H: 1.97%
C: 0.72%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: -1.25%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
depression treatment global growth market
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.